Raffi Agopian, MD
Colon & Rectal Surgery · Venice, FLNPI 1770584583
Payments from drug & device makers
Across 38 payments — averaging $181.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Johnson & Johnson$210
- Sanara Medtech Inc.$150
- Medtronic$142
- Acera Surgical, Inc.$134
- Axonics, Inc.$63
- plus $270 from 12 others
What the payments were for
- Travel & lodging$82712%
- Food & beverage$1,06815%
- Education$5,00073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $5,926 |
| Johnson & Johnson | 5 | $210 |
| Sanara Medtech Inc. | 1 | $150 |
| Medtronic | 3 | $142 |
| Acera Surgical, Inc. | 1 | $134 |
| Axonics, Inc. | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| QOL Medical, LLC | 1 | $34 |
| Palette Life Sciences, Inc. | 1 | $30 |
| Sanofi | 1 | $28 |
| Innovation Technologies Inc | 1 | $25 |
| Vivus LLC | 1 | $22 |
| Stryker | 1 | $18 |
| KARL Storz Endoscopy-america | 1 | $18 |
| Innocoll Pharmaceuticals Limited | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Myriad Genetic Laboratories, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,816
- CellerateRx$150
- Restrata Wound Matrix$134
How this compares
$6,895 in reported general payments places this provider in the 50th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 15 | $273 |
| Ibuprofen | 31 | $78 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $62 |
| Neomycin Sulfate | 14 | $19 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Venice
- Mark SolimanAltamonte Springs$887K
- Avraham BelizonBoca Raton$642K
- Jorge MarcetTampa$627K
- Eduardo Parra DavilaWest Palm Beach$598K
- Matthew AlbertAltamonte Springs$573K
- Jaime SanchezTampa$532K
- Allen ChudzinskiTampa$386K
- Rahila EssaniCelebration$379K
- Henry LujanMiami$378K
- Giovanna da Silva SouthwickWeston$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.